7.40
price up icon1.81%   0.22
after-market Handel nachbörslich: 7.40
loading

Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
26.79%
2.7338
3.7343 3.928 2.46 2.4666
Operating Income/Loss
26.79%
-2.7338
-3.7343 -3.928 -2.46 -2.4666
Nonoperating Income/Loss
28.22%
0.0481
0.067 0.0826 0.0521 0.0736
Income/Loss From Continuing Operations Before Tax
26.77%
-2.6857
-3.6673 -3.8454 -2.4078 -2.393
Income/Loss From Continuing Operations After Tax
26.77%
-2.6857
-3.6673 -3.8454 -2.4078 -2.393
Net Income/Loss
26.77%
-2.6857
-3.6673 -3.8454 -2.4078 -2.393
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.20%
2.044
1.9616 1.8441 1.104 16.01
Diluted Average Shares
4.20%
2.044
1.9616 1.8441 1.104 16.01
Basic Earnings Per Share
29.95%
-1.31
-1.87 -2.09 -2.18 -0.15
Diluted Earnings Per Share
29.95%
-1.31
-1.87 -2.09 -2.18 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):